“…Cytodiagnosis is considered a valuable tool in the management of soft tissue tumors since, in the hands of expert pathologists, it can afford a diagnostic specificity of >90%. 7,8,13,16,18,20,35,40,49,50 Nonetheless, FNA is not without pitfalls, some of which derive from the nature of the tumors themselves, such as scarcity of cells in the aspirate of some lesions, tumor heterogeneity 28,30 and the exclusively focal nature of certain sarcomatous growths. 42 Additional difficulties include the nontypical behavior of lesions, the large variety of fibroblast and myofibroblast proliferations with very poor cytoarchitectural expressivity, and the absence of strict criteria for the diagnosis of some sarcomas (e.g., nerve sheath sarcoma).…”